GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (STU:2XA) » Definitions » ROE % Adjusted to Book Value

Benevolent AI (STU:2XA) ROE % Adjusted to Book Value : -32.95% (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Benevolent AI ROE % Adjusted to Book Value?

Benevolent AI's ROE % for the quarter that ended in Dec. 2023 was -48.76%. Benevolent AI's PB Ratio for the quarter that ended in Dec. 2023 was 1.48. Benevolent AI's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was -32.95%.


Benevolent AI ROE % Adjusted to Book Value Historical Data

The historical data trend for Benevolent AI's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI ROE % Adjusted to Book Value Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - - -7.70 -82.35 -34.67

Benevolent AI Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only -13.75 -74.89 -15.28 -65.01 -32.95

Competitive Comparison of Benevolent AI's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Benevolent AI's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Benevolent AI's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Benevolent AI's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Benevolent AI's ROE % Adjusted to Book Value falls into.


;
;

Benevolent AI ROE % Adjusted to Book Value Calculation

Benevolent AI's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-51.31% / 1.48
=-34.67%

Benevolent AI's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-48.76% / 1.48
=-32.95%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Benevolent AI ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Benevolent AI's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI Business Description

Industry
Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.

Benevolent AI Headlines

No Headlines